At the time of writing, Twist Bioscience Corporation [TWST] stock is trading at $28.74, up 6.33%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The TWST shares have gain 10.71% over the last week, with a monthly amount glided 21.63%, and seem to be holding up well over a long-time horizon.
On 19, January 2023, Twist Bioscience to Report Fiscal 2023 First Quarter Financial Results on Friday, February 3, 2023. In a post published today on Yahoo Finance, Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2023 first quarter ended December 31, 2022, before the opening of the market on Friday, February 3, 2023. The company plans to hold a conference call and live audio webcast for analysts and investors at 8:00 a.m. Eastern Time to discuss its financial results and provide an update on the company’s business. The press release with the financial results will be accessible from the company’s website prior to the conference call through the Investor Relations section under the “Company” tab at www.twistbioscience.com.
From an analyst’s perspective:
Twist Bioscience Corporation [NASDAQ: TWST] stock has seen the most recent analyst activity on January 05, 2023, when Scotiabank initiated its Sector Outperform rating and assigned the stock a price target of $33. Previously, Evercore ISI upgraded its rating to Outperform on January 03, 2023, and elevated its price target to $36. William Blair initiated its recommendation with a Outperform. Goldman started tracking with a Neutral rating for this stock on June 04, 2021, and assigned it a price target of $110. In a note dated April 12, 2021, Piper Sandler initiated an Overweight rating and iterated a target price of $150 on this stock.
For the past year, the stock price of Twist Bioscience Corporation fluctuated between $21.78 and $66.15. Currently, Wall Street analysts expect the stock to reach $35.88 within the next 12 months. Twist Bioscience Corporation [NASDAQ: TWST] shares were valued at $28.74 at the most recent close of the market. An investor can expect a potential return of 24.84% based on the average TWST price forecast.
Analyzing the TWST fundamentals
According to Twist Bioscience Corporation [NASDAQ:TWST], the company’s sales were 57.31 billion in the recent quarter, which represents an 50.80% jump. Gross Margin for this corporation currently stands at +41.38% with Operating Margin at -122.33%, Pretax Margin comes in at -112.14%, and Net Margin reading is -107.02%.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 26.79 points at the first support level, and at 24.83 for the second support level. However, for the 1st resistance point, the stock is sitting at 30.09, and for the 2nd resistance point, it is at 31.43.
Twist Bioscience Corporation [TWST] reported earnings per share of -$1.08 for its fiscal quarter that ended on 6/29/2022. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$1.31/share, meaning a difference of $0.23 and a surprise factor of 17.60%. By comparison, the stated earnings for the previous quarter ended on 3/30/2022 were -$1.13 per share as compared to estimates of -$1.28 per share, a difference of $0.15 representing a surprise of 11.70%.
Ratios To Look Out For
It is important to note that Twist Bioscience Corporation [NASDAQ:TWST] has a current ratio of 6.60. As well, the Quick Ratio is 6.15, while the Cash Ratio is 5.57. Considering the valuation of this stock, the price to sales ratio is 9.33, the price to book ratio is 2.52.
Transactions by insiders
Insider trading has also been a hot topic recently, with 8 insiders purchasing 163,316 shares and 28 selling 12,858 shares in the past 3 months. Recent insider trading involved Banyai William, that happened on Jan 04 when 292.0 shares were sold., Banyai William completed a deal on Nov 21 to sell 1275.0 shares. Meanwhile, Banyai William sold 379.0 shares on Oct 25.